Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) Capital Expenditures (2020 - 2023)

Historic Capital Expenditures for ImageneBio (IMA) over the last 4 years, with Q4 2023 value amounting to $262000.0.

  • ImageneBio's Capital Expenditures rose 1341.99% to $262000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $414000.0, marking a year-over-year decrease of 7106.92%. This contributed to the annual value of $414000.0 for FY2023, which is 7106.92% down from last year.
  • ImageneBio's Capital Expenditures amounted to $262000.0 in Q4 2023, which was up 1341.99% from $152000.0 recorded in Q1 2023.
  • ImageneBio's 5-year Capital Expenditures high stood at $910000.0 for Q2 2022, and its period low was -$1000.0 during Q2 2020.
  • Moreover, its 4-year median value for Capital Expenditures was $209000.0 (2021), whereas its average is $312214.3.
  • As far as peak fluctuations go, ImageneBio's Capital Expenditures skyrocketed by 1880000.0% in 2021, and later tumbled by 9606.67% in 2022.
  • Quarter analysis of 4 years shows ImageneBio's Capital Expenditures stood at $638000.0 in 2020, then fell by 13.79% to $550000.0 in 2021, then crashed by 58.0% to $231000.0 in 2022, then increased by 13.42% to $262000.0 in 2023.
  • Its last three reported values are $262000.0 in Q4 2023, $152000.0 for Q1 2023, and $231000.0 during Q4 2022.